| JXHS2000028 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-03-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-02-03 | view |
| JXHL1700226 | 达格列净二甲双胍缓释片 | dapagliflozin;metformin hydrochloride | Tablet, extended release | Chemical Drugs(5.1) | Import Drug Application | 2017-12-13 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-11-09 | view |
| JYHB2001526 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-08-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-10-23 | view |
| JYHB1801041 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2018-08-31 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-09-05 | view |
| JYHB1700827 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-06-08 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-10-20 | view |
| JXHL1500156 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-23 | view |
| JYHB1900890 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-07-26 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-12-26 | view |
| JYHB1900693 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-06-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2019-06-07 | view |
| JYHB1701015 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-08-08 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-11-19 | view |
| JXHS1500112 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-12-16 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-20 | view |
| JYHB1800328 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2018-03-22 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-06-12 | view |
| JXHL1700009 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2017-02-06 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-06-27 | view |
| JYHB1900717 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-06-22 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-16 | view |
| JXHL1900086 | 达格列净沙格列汀片 | dapagliflozin;saxagliptin | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-05-09 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2019-05-08 | view |
| JYHB1700960 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-07-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-11-09 | view |
| JYHB2001525 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-08-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-10-23 | view |
| JYHB1801040 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2018-08-31 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-09-05 | view |
| JYHB1700826 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-06-08 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-10-20 | view |
| JXHL1500157 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-23 | view |
| JYHB1900889 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-07-26 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-12-26 | view |
